Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast CancerN. Engl. J. Med 2019 May 16;380(20)1929-1940, F André, E Ciruelos, G Rubovszky, M Campone, S Loibl, HS Rugo, H Iwata, P Conte, IA Mayer, B Kaufman, T Yamashita, YS Lu, K Inoue, M Takahashi, Z Pápai, AS Longin, D Mills, C Wilke, S Hirawat, D Juric
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.